Results 101 to 110 of about 56,789 (216)

Adapting CBT-E for the Middle East: addressing regional gaps in eating-disorder treatment. [PDF]

Front Psychiatry
El Khazen C, Sidani M, Abu Taha H, Melisse B.   +3 more
europepmc   +1 more source

Collaborative care intervention for risky opioid use among primary care patients: The STOP randomized clinical trial

Addiction, EarlyView.
Abstract Background and aims Individuals who engage in illicit or nonmedical opioid use may have elevated risk of health and social consequences, including progression to opioid use disorder (OUD). Preventive interventions to reduce this risk are lacking. This trial tested the impact of a primary care‐integrated collaborative care approach for reducing
Jennifer McNeely, Geetha A. Subramaniam, Rebecca Stone, Shayna Mazel, Noa Appleton, Yasna Rostam‐Abadi, Amanda M. Bunting, Yidan Shi, Travis I. Lovejoy, Lillian Gelberg, Donna Beers, Margaret Kline, Song Zhang, Tobie Kim, Ashley Case, Jennifer McCormack, Michael A. Incze, Jane M. Liebschutz, the STOP trial site principal investigators, Karen Alexander, Seuli Bose Brill, Sarah Kawasaki, Adam J. Gordon, Hyunouk Hong   +23 more
wiley   +1 more source

Psychological Subtypes and Intervention Strategies in Burning Mouth Syndrome: A Narrative Review. [PDF]

J Pain Res
Li J, Mu J, Sun T, Li X, Wu F, Zhuo Y, He J, Liu F.   +7 more
europepmc   +1 more source

Beyond abstinence: Redefining success in cannabis use disorder treatment

Addiction, EarlyView.
Abstract Background Over two decades of pharmacotherapy research has yet to yield a consistently effective medication for cannabis use disorder (CUD), in part because clinical trials have frequently prioritized abstinence as a primary or key endpoint.
Tobias B. Atkin, Frances R. Levin, John Mariani, Christina A. Brezing   +3 more
wiley   +1 more source

Adjunctive Psychosocial Interventions and Opioid Abstinence Among Patients Receiving Buprenorphine: A Randomized Clinical Trial.

JAMA Netw Open
Lent MR, Hurstak EE, Lynch KG, Loscalzo E, Mazur K, Lugo HL, Dugosh KL.   +6 more
europepmc   +1 more source

Controlled breathing and heart rate variability biofeedback for substance use‐related outcomes: A systematic review and meta‐analysis

Addiction, EarlyView.
Abstract Background and aim Substance use disorders (SUDs) contribute significantly to global social and economic burden. Breathing‐based interventions offer a low‐cost, scalable adjunct or alternative to traditional treatment, yet their effects on substance use‐related outcomes has not been systematically evaluated.
Ariel Dart Roxburgh, Bosco Rowland, Dan I. Lubman, Sukhjit Kaur Bains, May Anne Pek, Bernard Tso, Victoria Manning, Shalini Arunogiri   +7 more
wiley   +1 more source

Enzyme-Induced Supramolecular Proteolysis-Targeting Chimeras Enable Tumor-Targeted Protein Degradation. [PDF]

JACS Au
Liang C, Ma X, Chen X, Dai C, Sun X, Li J, Dong R, Dong P, Wang M.   +8 more
europepmc   +1 more source

Psychological change processes in alcohol use disorder: A qualitative study of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) with cognitive behavioural therapy

Addiction, EarlyView.
Abstract Background and aims This study qualitatively explored psychological change processes as described by participants and therapists within a phase 2a clinical trial evaluating the safety, tolerability, and preliminary efficacy of a single dose of intranasal 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT; BPL‐003) administered alongside psychological
Mathieu Seynaeve, Fiona Dunbar, Anna O. Ermakova, Luke Mitcheson, James J. Rucker, Anthony Cleare, John Marsden   +6 more
wiley   +1 more source

Investigating the Average Glandular Dose and Exposure Parameters in Mammography Based on Compressed Breast Thickness and Imaging Projection: A Single-Centre Study in Jeddah, Saudi Arabia. [PDF]

Healthcare (Basel)
Alamoudi D, Babgi A, Bazuhayr L, Alsharif S, Alhalwani AY, Alamoudi D.   +5 more
europepmc   +1 more source